XML 50 R41.htm IDEA: XBRL DOCUMENT v3.24.3
Borrowings (Details) - EUR (€)
€ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 24 Months Ended
Dec. 31, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2019
Sep. 30, 2024
Dec. 10, 2018
Disclosure of detailed information about borrowings [line items]                
Total borrowings € 4,292       € 4,292   € 4,510  
Current portion             (4,510)  
Non Current portion 4,292       4,292      
Result on derecognition of financial liabilities     € 1,357 € 1,866        
Pontifax and Kreos warrants                
Disclosure of detailed information about borrowings [line items]                
Warrants, economic lifetime   5 years            
Innovation credit                
Disclosure of detailed information about borrowings [line items]                
Accrued interest 1,393       1,393   1,611  
Total borrowings 2,899       2,899   2,899  
Current portion             € (2,899)  
Notional amount               € 3,907
Total conditional waiver of debt € 4,510              
Repayment of borrowings         € 1,008      
Convertible loans Amylon Therapeutics B.V. [Member]                
Disclosure of detailed information about borrowings [line items]                
Interest rate (as percent)           8.00%    
Convertible loans Amylon Therapeutics B.V. [Member] | Minimum                
Disclosure of detailed information about borrowings [line items]                
Period upon which unconverted loans become payable on demand           24 months    
Convertible loans Amylon Therapeutics B.V. [Member] | Maximum                
Disclosure of detailed information about borrowings [line items]                
Debt instrument convertible term           36 months    
Period upon which unconverted loans become payable on demand           36 months